Financial Products
All Our Solutions

Back to the list of financial products


BioMed Propulsion Program

This program is administered by Investissement Québec under the responsibility of the Ministère de l’Économie, de la Science et de l’Innovation.

 

Objectives

The primary objective of this program is to provide financial support for Québec life-sciences companies with strong growth potential to help them commercialize the results of their research while encouraging private investors to play an active role.

 

More specifically, the program’s goals are as follows:

 

  • Improve access to funding for companies in the life-sciences industry
  • Encourage the viability and growth of companies with high growth potential
  • Support product development
  • Help maintain and create long-term, high-quality jobs
  • Spur R&D investments for biotechnology companies
  • Boost investment to support commercialization efforts by medical technology companies

Eligible Corporations

For-profit companies in the life-sciences industry qualify if their head office (where business decisions are made) and most jobs are in Québec.

 

More specifically, the BioMed Propulsion program is designed for companies active in the following sectors:

 

  • Human or animal health biotechnology : companies that are primarily engaged in R&D and incur expenses primarily for R&D. These companies develop or manage intellectual property associated with a product, platform or process related to human or animal health. Human health companies must at least have one product in the clinical trial stage; in other words, they must have received authorization from a regulatory agency to conduct clinical trials on humans (IND). Animal health companies must at least have obtained certification from a regulatory agency.
  • Medical technology : companies whose primary activities are designing, developing, manufacturing and commercializing medical devices, which are defined in Canada as any instrument, apparatus, contrivance or article that is manufactured or sold for use in:
    • diagnosing, treating, mitigating or preventing a disease, disorder or abnormal physical state, or its symptoms, in human beings or animals;
    • restoring, correcting or modifying organic functions in human beings or animals or the functioning of any part of their bodies.

The company must at least have obtained certification from a regulatory agency.

 

  • Companies supplying specialized but substitutable products for local markets such as medical, dental, ophthalmic, prosthetic and clinical laboratories;
  • Distribution companies or companies engaged solely in activities related to the commercialization of medical devices;
  • Information technology and communication companies in the health field that cater solely to consumers.

Eligibility Requirements

 

In the course of a financing operation, the company must obtain one or more new private investments in the form of equity stakes or shares totalling three times the amount of the financial assistance requested.

 

The company must supply a due diligence review conducted by the private investors. If it fails to do so, a due diligence review will be conducted by an external consultant at the company’s expense.

Financing Details

 

Financial assistance takes the form of an equity loan.

 

The amount of the financial assistance is subject to the following minimum and maximum thresholds:

 

  • For biotechnology companies: $2.5 million to $10 million
  • For medical technology companies: $0.5 million to $10 million

Other Conditions

  • The maximum financing term is 10 years.
  • It is possible to obtain a deferral on capital repayment.
  • Disbursement of the loan will be prorated to investor disbursements.
  • The capital will be repaid on a yearly basis at a rate equal to at least 25% of the funds generated by commercial operations.
  • The loan will bear interest at Investissement Québec’s prime rate.
  • The company will be required to pay a premium in the form of stock or unit options and calculated as 15% of the amount of the loan in order to offset risks.
  • Securities on the company’s assets will be required.

 

Fees

 

For any project funded under this program, the company will be required to pay a management fee.

To Apply

For further information or to apply, contact an Investissement Québec expert at
1 844 474-6367.

For more information, please contact:

Ministère de l’Économie, de la Science et de l’Innovation.

Email : biomed@economie.gouv.qc.ca

 

November 2016

Share

Contact your expert

André Williot

Client Service Officer

1 844 474-6367